(Q53912819)

22 May 2018

title

Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency. (English)

1 reference

22 May 2018

author name string

Murray RD

1

1 reference

22 May 2018

Howell SJ

2

1 reference

22 May 2018

Lissett CA

3

1 reference

22 May 2018

Shalet SM

4

1 reference

22 May 2018

publication date

1 May 2000

1 reference

22 May 2018

published in

Clinical Endocrinology

1 reference

22 May 2018

volume

52

1 reference

22 May 2018

issue

5

1 reference

22 May 2018

page(s)

537-542

1 reference

22 May 2018

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

The safety profile of GH replacement therapy in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Clinical aspects of growth hormone deficiency in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Reduced bone mineral density in patients with adult onset growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Which adults develop side-effects of growth hormone replacement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Beneficial effects of growth hormone treatment in GH-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Premature mortality due to cardiovascular disease in hypopituitarism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Decreased psychological well-being in adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2000.00971.X

10.1046/J.1365-2265.2000.00971.X

21 January 2018

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

10792331

1 reference

22 May 2018